Pancreatic Cancer Research
Developing revolutionary imaging technologies and biomarkers to detect pancreatic cancer at its earliest, most treatable stages
Our Pancreatic Cancer Program
Pancreatic cancer remains one of the most challenging cancers to detect early, with most cases diagnosed at advanced stages when treatment options are limited. The Canary Foundation's pancreatic cancer research program, established in 2005, focuses on breakthrough technologies that can identify this cancer when it's still treatable.
The team's July 2026 report describes clinical research into handheld point-of-care ultrasound (POCUS), microbubble contrast enhancement, and quantitative ultrasound for pancreatic imaging.
Microbubble Technology
Clinical research evaluating microbubble contrast agents to improve visualization of the pancreas with ultrasound.
POCUS Development
Evaluating wireless handheld ultrasound that connects to a mobile device for bedside pancreatic imaging, including comparisons with endoscopic ultrasound.
Gene Mutation Discovery
In 2006, we discovered pancreatic cancer gene mutations, advancing our understanding of the genetic factors that drive this aggressive cancer.
Advanced Ultrasound
Analyzing radio-frequency ultrasound data to investigate tissue characteristics beyond conventional visual imaging.
What is the pancreas team evaluating?
The July 2026 research update describes trials of pancreatic imaging compared with endoscopic ultrasound, testing of contrast enhancement with microbubbles, and analysis of radio-frequency data. These are research approaches under evaluation, rather than a claim that a new population screening test is available.
Research Milestones
Program Established
First Scientific Symposium and pancreatic cancer team formed
Gene Mutations Discovered
Advanced understanding of genetic factors in pancreatic cancer
Microbubble Technology Developed
Revolutionary imaging for sub-millimeter tumor detection
POCUS Advancement
Point-of-care ultrasound for accessible screening
Current Research Initiatives
CA-19-9 Biomarker Enhancement
Improving the specificity of CA-19-9 testing through combination with imaging and other biomarkers for more accurate early detection.
High-Risk Screening Protocols
Developing screening guidelines for individuals with family history, genetic mutations, or chronic pancreatitis who face elevated risk.
Artificial Intelligence Integration
Using machine learning to analyze imaging data and identify subtle patterns that may indicate early-stage pancreatic cancer.
Support Pancreatic Cancer Research
Help us continue developing breakthrough technologies that can detect pancreatic cancer when it's still treatable.